Registration for a live webinar on 'Innate immunity, inflammation and cancer' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Microbiota: Agents for Health and Disease
-
1. Introduction to microbiota: agents for health and disease
- Prof. B. Brett Finlay
- The Human Microbiota
-
2. The human microbiome project
- Prof. George Weinstock
-
3. The human indigenous microbiota
- Prof. David Relman
-
4. Gut microbiota, chronic inflammation and metabolic syndrome
- Prof. Andrew Gewirtz
- Microbiota and Disease
-
5. Role of the microbiota in asthma
- Prof. B. Brett Finlay
-
6. Disappearing microbiota and human metabolic health
- Prof. Martin Blaser
-
8. Gram+ bacterial microbiota - Yin & Yang of infectious disease
- Prof. P. Patrick Cleary
-
9. Salmonella diarrhea: contributions from the microbiota, the pathogen and the host
- Prof. Dr. Wolf-Dietrich Hardt
-
11. Microbiota and oral disease
- Prof. Dennis Cvitkovitch
-
12. Microbiota and inflammatory bowel disease
- Prof. Janet Jansson
- Host Responses
-
13. The role of the enteric microbiota in T cell differentiation
- Prof. Dan Littman
-
15. Intestinal microbiota and the brain-gut axis
- Prof. Stephen Collins
- Preventatives and Therapeutics
-
16. Probiotics
- Dr. Gregor Reid
- Archived Lectures *These may not cover the latest advances in the field
-
17. A new frontier in biology: deciphering the molecular language of symbiosis
- Prof. Margaret McFall-Ngai
-
18. Probiotics and prebiotics
- Prof. Glenn Gibson
Printable Handouts
Navigable Slide Index
- Introduction
- Koch's postulates (1882)
- Case
- Clostridium difficile (1)
- Clindamycin associated colitis due to C. difficile
- Clostridium difficile (2)
- C. difficile and the gastrointestinal microbiota
- "Community thinking"
- How to study the gut microbiota?
- 16S rRNA
- Antibiotic-associated diarrhea (AAD)
- Microbial ecology of AAD
- Microbial community associated with AAD
- The enterome and gastrointestinal homeostasis
- C. difficile and antibiotic-associated diarrhea
- Patients/clinical results
- Microbial ecology: diversity
- Collectors curves/rarefaction
- Initial and recurrent C. difficile rarefaction
- C. difficile colitis - microbial ecology insights
- How microbes defend and define us
- Resilience of gut microbial community structure
- Microbial communities in mice
- Microbial response to antibiotic stress (1)
- Microbial response to antibiotic stress (2)
- Microbial community diversity and antibiotics
- C. difficile in model systems
- C. difficile associated disease -a mouse model(1)
- C. difficile associated disease -a mouse model(2)
- Dissecting role of antibiotics
- Two groups of C. difficile treated mice
- A normal mouse colon
- A colon from an animal affected by c. difficile (1)
- An infected animal with a benign response
- A colon from an animal affected by c. difficile (2)
- Colon histopathology difference
- Vero cell cytotoxin assay on tissue
- C. difficile load in tissues
- Differences in microbial communities
- Cefoperazone treatment (1)
- Cefoperazone treatment (2)
- Microbial ecology in cefoperazone treated mice
- Survival in cefoperazone treated mice
- Model
- Summary
- Acknowledgements
Topics Covered
- C. difficile and the antibiotic-associated colitis
- Changes in the microbiota due to antibiotics predisposed to C. difficile infection
- Use of culture-independent techniques to study the gut microbiota
- Antibiotics can have reproducible effects on the gut microbiota
- Animal models and human studies provide insight into the role of the gut microbiota in mediating colonization resistance against C. difficile infection
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Young, V. (2011, September 27). The microbiota in the development of colitis due to Clostridium difficile infection [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 20, 2024, from https://hstalks.com/bs/2096/.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Vincent Young has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The microbiota in the development of colitis due to Clostridium difficile infection
Published on September 27, 2011
41 min
A selection of talks on Infectious Diseases
Hide